Upholding high standards throughout the research process of studies in pharmacoepidemiology and pharmacovigilance based on the principles of scientific independence, transparency and robust methodologies is at the core of the ENCePP initiative. The Code specifically aims to avoid financial, commercial or institutional interests of the study funder and potential personal interests of researchers that could influence the study results in any particular direction. To recognise studies following these ENCePP core principles the ENCePP Seal has been introduced.
Studies bearing the ENCePP Seal are performed taking into account the relevant methodological research standards described in the ENCePP Guide on Methodological Standards in Pharmacoepidemiology and conducted in line with the rules and requirements for independent and transparent research laid down in the ENCePP Code of Conduct and in established international guidelines such as the World Medical Association Declaration of Helsinki and the European Code of Conduct for Research Integrity.
The ENCePP Seal publicly identifies studies in the EU PAS Register that adhere to the entirety of the Code’s provisions. Reference to the Seal is encouraged in publications arising from the study.
Studies conducted in accordance with the following principles may qualify for the ENCePP Seal:
ANY pharmacoepidemiological and pharmacovigilance study may qualify for the ENCePP Seal if ALL of the following conditions are met and the respective provisions are implemented:
Signed Checklist of the ENCePP Code of Conduct (Annex 2)
Signed Declaration on compliance with the ENCePP Code of Conduct (Annex 3)
Signed Declaration of Interests (Annex 5)
The (primary) lead investigator publishes the research results in the EU PAS Register.
Researchers that follow the provisions of the ENCePP Code of Conduct in its entirety are encouraged to consider applying for the ENCePP Seal if the above conditions are met.
The flow chart below shows the steps of applying for the ENCePP Seal including timelines for the submission of documents to the ENCePP Secretariat. The application process should be started at least one month prior to the actual study start date to ensure steps 1 and 2 are completed satisfactorily before the study commences.
The original version of the full study protocol, i.e. the version at the time of study start, together with the final version shall be made publicly available, without delay after the final study report is available. However, the (primary) lead investigator may decide to publish the protocol at an earlier point in time if he so wishes and provided that the study funder agrees.
To confirm a commitment to comply with the provisions of the Code, the (primary) lead investigator of the study must print, complete and sign the documents listed under point 2.3 of the conditions above.
An electronic copy (PDF) of these signed documents must be emailed to the ENCePP Secretariat prior to study start and the study must be registered in the EU PAS Register together with the full protocol.
Once the application is accepted by the ENCePP Secretariat the declaration and the checklist will be made publicly available in the EU PAS Register and the ENCePP Seal will be displayed next to the study title as a symbol for adherence to the Code.
The (primary) lead investigator should inform the ENCePP Secretariat if the study deviates from and/or no longer fulfills the criteria for the ENCePP Seal. Any failure to comply with the entirety of the provisions of the Code may be considered a breach of the declaration (Annex 3) and relevant documentation, and the ENCePP Seal will be removed from the EU PAS Register.
The ENCePP Secretariat is the point of reference for the (primary) lead investigator and funder for enquiries about the conditions for the ENCePP Seal and the practical implementation of the Code’s provisions.